Longeveron Inc. (LGVN): EPS (Diluted)
-$1.29
Year ended 2025-12-31
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$1.29 | n/m | 2026-03-17, From 2025-01-01 |
| 2024-12-31 | -$2.62 | n/m | 2026-03-17, From 2024-01-01 |
| 2023-12-31 | -$10.22 | n/c | 2025-02-28, From 2023-01-01 |
| 2022-12-31 | -$0.90 | n/m | 2024-02-27, From 2022-01-01 |
| 2021-12-31 | -$0.90 | n/a | 2023-03-14, From 2021-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Longeveron Inc. (LGVN) | 2025-12-31 | -$1.29 | n/m |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | -$3.06 | n/m |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | -$9.13 | n/m |
| Vistagen Therapeutics, Inc. (VTGN) | 2026-03-31 | -$1.83 | n/m |
| IGC Pharma, Inc. (IGC) | 2025-03-31 | -$0.09 | n/m |
| Bespoke Extracts, Inc. (BSPK) | 2024-12-31 | -$0.10 | n/m |
| Cannapharmarx, Inc. (CPMD) | 2025-12-31 | -$0.02 | n/m |
| Northwest Biotherapeutics Inc (NWBO) | 2025-12-31 | -$0.04 | n/m |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | -$1.20 | n/m |
Compare LGVN, NEUP, SXTC, VTGN side by side · Screen every company in Pharmaceutical Preparations ↗